Clinical Trial Update: Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating exenatide in combination with insulin to preserve beta-cell function in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Insulin (insulin)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED